MAPK3 and colorectal carcinoma: Consistent with this, Western blot analysis revealed that statin treatment markedly decreased the ratio of phosphorylated ERK1/2 to total ERK1/2 in the CRC cells [25], confirming suppression of MAPK pathway activation.